CTT Pharmaceutical Holdings, Inc. (NASDAQ:CTTH) | WebDisclosure

Basculer en Français

10374	Companies
216189	Keywords
145888	Articles
114464	Press releases

Headlines Articles Press releases CTT Pharmaceutical Holdings, Inc.

Home
Companies
CTT Pharmaceutical Holdings, Inc.

PRESS RELEASE

published on 02/25/2025 at 13:15, 1 year 2 months ago

CTT Pharma Gives Update On U.S. and European Patents
CTT Pharmaceutical Holdings, Inc. receives intention to grant additional claims for diabetes drug patent from European Patent Office and plans to utilize micelle technology for enhanced drug delivery. Seeking opportunities for pharmaceutical companies

Drug Delivery European Patent Office Micelle Technology CTT Pharmaceutical Holdings Diabetes Drug Patent
BRIEF

published on 02/12/2025 at 13:20, 1 year 2 months ago

CTT Pharma progresse dans la subvention NSF pour les bandelettes de nicotine

Innovation CTT Pharma Bandelettes De Nicotine Subvention NSF Épidémie De Tabagisme
BRIEF

published on 02/12/2025 at 13:20, 1 year 2 months ago

CTT Pharma Progresses in NSF Grant for Nicotine Strips

Innovation CTT Pharma Nicotine Strips NSF Grant Tobacco Epidemic
PRESS RELEASE

published on 02/12/2025 at 13:15, 1 year 2 months ago

CTT Pharma Gives Update On NSF Grant
CTT Pharmaceutical Holdings, Inc. (OTC:CTTH) advances to the next round of NSF grant program with their patented fast dissolving nicotine strips, aiming to combat the global tobacco epidemic

Public Health Tobacco Epidemic CTT Pharmaceutical Holdings NSF Grant Program Fast Dissolving Nicotine Strips
BRIEF

published on 02/05/2025 at 13:20, 1 year 3 months ago

CTT Pharmaceuticals Welcomes Dr. Katherine Cole as Independent Director

Independent Director Biomedical Science CTT Pharmaceuticals Katherine Cole NIH Experience
BRIEF

published on 02/05/2025 at 13:20, 1 year 3 months ago

CTT Pharmaceuticals accueille le Dr Katherine Cole au poste de directrice indépendante

Administrateur Indépendant Katherine Cole CTT Pharmaceutique Expérience Du NIH Sciences Biomédicales
PRESS RELEASE

published on 02/05/2025 at 13:15, 1 year 3 months ago

CTT Pharma Adds Independent Director With NIH/NSF Experience
CTT Pharmaceuticals Holdings, Inc. welcomes Dr. Katherine Cole, a highly accomplished professional with a Ph.D. in Pathology, as an Independent Director. Dr. Cole's extensive experience in cancer research and academia brings valuable insight to CTT

Bioavailability Drug Delivery CTT Pharmaceuticals Dr. Katherine Cole Ph.D. In Pathology
BRIEF

published on 02/03/2025 at 13:20, 1 year 3 months ago

CTT Pharma réduit le nombre d'actions autorisées

Actionnaires Structure Du Capital Réduction Des Parts CTT Pharma Liste De Mise À Niveau OTCQB
BRIEF

published on 02/03/2025 at 13:20, 1 year 3 months ago

CTT Pharma Reduces Authorized Share Count

Shareholders Capital Structure Share Reduction CTT Pharma OTCQB Uplist
PRESS RELEASE

published on 02/03/2025 at 13:15, 1 year 3 months ago

CTT Pharma Reduces Authorized Share Count
CTT Pharmaceuticals Holdings, Inc. reduces authorized share count by 150 million shares, demonstrating commitment to optimizing capital structure and value to shareholders. Company to uplist to OTCQB

OTCQB Capital Structure CTT Pharmaceuticals Authorized Share Count Micelle Technology

Accesswire

Published on 05/09/2026 at 01:55, 1 day 18 hours ago

Prospect Ridge Announces Board Resignation
Published on 05/09/2026 at 01:40, 1 day 18 hours ago

Findev Inc. Issues Corrective Disclosure
Published on 05/09/2026 at 01:30, 1 day 18 hours ago

Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 1 day 20 hours ago

Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 23:01, 1 day 21 hours ago

Water Ways Announces Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 05/10/2026 at 16:05, 4 hours 12 minutes ago

RingConn Gen 3 Smart Ring Opens for Pre-Order: Bringing Vascular Insights to Effortless Everyday Wear
Published on 05/10/2026 at 14:00, 6 hours 17 minutes ago

MBC GROUP DELIVERS RESILIENT 1Q 2026 PERFORMANCE ANCHORED BY STRONG MBC SHAHID GROWTH
Published on 05/10/2026 at 11:45, 8 hours 32 minutes ago

Hisense Kicks Off FIFA World Cup 2026™ Campaign, Bringing Fans Closer Through "Innovating a Brighter Life"
Published on 05/09/2026 at 19:05, 1 day 1 hour ago

LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 1 day 23 hours ago

EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations

Les Echos

Published on 05/07/2026 at 19:15, 3 days 1 hour ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 3 days 1 hour ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 3 days 1 hour ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 3 days 1 hour ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 3 days 1 hour ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE